Sihuan Pharmaceutical Holdings Group (0460) Stock Statistics & Valuation Metrics

Sihuan Pharmaceutical Holdings Group has a market cap or net worth of HK$12.04B. The enterprise value is HK$7.52B.

Sihuan Pharmaceutical Holdings Group has 9,329,999,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sihuan Pharmaceutical Holdings Group’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -1.87%.

The current PE Ratio of Sihuan Pharmaceutical Holdings Group is 34.2. Sihuan Pharmaceutical Holdings Group’s PEG ratio is -0.09.

In the last 12 months, Sihuan Pharmaceutical Holdings Group had revenue of 1.90B and earned -216.66M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was 112.15M and capital expenditures -49.46M, giving a free cash flow of 62.70M billion.

Sihuan Pharmaceutical Holdings Group pays an annual dividend of HK$0.011, resulting in a dividend yield of 0.87%

Sihuan Pharmaceutical Holdings Group upcoming earnings date is Sep 1, 2026, TBA (Confirmed).

Sihuan Pharmaceutical Holdings Group as a current ratio of 1.73, with Debt / Equity ratio of 15.59%

In the past 12 months, Sihuan Pharmaceutical Holdings Group has paid 43.26M in taxes.

Sihuan Pharmaceutical Holdings Group EV to EBITDA ratio is -15.16, with an EV/FCF ratio of 55.02.

Sihuan Pharmaceutical Holdings Group has HK$3.60B in cash and marketable securities with HK$1.03B in debt, giving a net cash position of HK$2.57B billion.

Gross margin is 68.81%, with operating margin of -7.27%, and net profit margin of -11.40%.

The average price target for Sihuan Pharmaceutical Holdings Group is HK$2.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy